Articles From: 2015/2/2 - Dicerna Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Clinical Trial of DCR-MYC, an Investigational RNAi Therapeutic Targeting the MYC Oncogene, in Patients with Advanced Hepatocellular Carcinoma to 2015/2/2 - Lingerfelt CommonWealth Partners Acquires Portfolio of Five Hotels


2015/2/2
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi therapeutics, today announced that the first patient has been dosed in a global Phase 1b/2 clinical trial of DCR-MYC, an investigational Dicer substrate short interfering RNA (DsiRNA) therapeutic, in patients with advanced hepatocellular carcinoma (HCC). This new trial expands the development program for DCR-MYC, which is also being studied in a Phase 1 clinical trial in patients with solid tumors and hematological malignancies.
Sign-up for 2015/2/2 - Dicerna Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Clinical Trial of DCR-MYC, an Investigational RNAi Therapeutic Targeting the MYC Oncogene, in Patients with Advanced Hepatocellular Carcinoma investment picks
2015/2/2
PETAH TIKVA, Israel, Feb.
Sign-up for 2015/2/2 - Delnet International Corp. Taps Gilat to Provide Cellular Backhaul Solution for SMART investment picks
2015/2/2
BROOMFIELD, Colo.
Sign-up for 2015/2/2 - Gartner Names Level 3 as a Challenger in 2015 Magic Quadrant for Network Services, Global investment picks
2015/2/2
CHARLOTTE, N.C. , Feb.
Sign-up for 2015/2/2 - Sensors Unlimited Introduces its Fastest SWIR 2048-Pixel Line Scan Camera to Support Medical Diagnosis investment picks
2015/2/2
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault will present a corporate overview of the Company and meet with investors at the 17 th Annual BIO CEO & Investor Conference in New York City.
Sign-up for 2015/2/2 - NephroGenex to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/2
Bombardier and Chorus Sign Purchase Agreement for up to 23 Q400 NextGen Aircraft and Launch New Extended Service Program for Dash 8-300 Aircraft Canada NewsWire Q400 aircraft to be operated by Jazz under the Air Canada Express brand TORONTO and HALIFAX , Feb.
Sign-up for 2015/2/2 - Bombardier and Chorus Sign Purchase Agreement for up to 23 Q400 NextGen Aircraft and Launch New Extended Service Program for Dash 8-300 Aircraft investment picks
2015/2/2
Advisory - Chorus Aviation Inc. update and analyst call Canada NewsWire HALIFAX , Feb.
Sign-up for 2015/2/2 - Advisory - Chorus Aviation Inc. update and analyst call investment picks
2015/2/2
XI'AN, China , Feb.
Sign-up for 2015/2/2 - CREG Receives NASDAQ Notice of Bid Price Deficiency investment picks
2015/2/2
The board of directors of GATX Corporation (NYSE:GMT) declared a quarterly dividend of $0.38 per common share, payable March 31, 2015, to shareholders of record on February 27, 2015.
Sign-up for 2015/2/2 - GATX Corporation Announces Quarterly Dividend investment picks
2015/2/2
BOSTON , Feb.
Sign-up for 2015/2/2 - Columbia Laboratories to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/2/2
Luxury Cliff Top Resort Ready to Welcome Guests CHEVY CHASE, Md.
Sign-up for 2015/2/2 - The Ritz-Carlton, Bali Officially Opens, Enlivening The Senses With True Balinese Hospitality investment picks
2015/2/2
EINDHOVEN, Netherlands, Feb.
Sign-up for 2015/2/2 - NXP, Creditcall and ViewAt Technology Introduce Secure Solution for NFC-enabled Mobile Point of Sale investment picks
2015/2/2
Hudson Pacific Properties, Inc. (the “Company”) (NYSE: HPP) today announced the tax treatment for its 2014 common and preferred stock dividends.
Sign-up for 2015/2/2 - Hudson Pacific Properties, Inc. Announces 2014 Dividend Tax Treatment investment picks
2015/2/2
http://www.marketwire.com/library/MwGo/2015/2/1/11G032037/Stifel_logo-440722595205.jpg ST.
Sign-up for 2015/2/2 - Stifel Public Finance Group Ranks No. 1 in Municipal Negotiated Issues in 2014 investment picks
2015/2/2
http://media3.marketwire.com/docs/prophecy_dev_logo_ms_200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for 2015/2/2 - Prophecy's Pulacayo Tailings Piles Samples Assayed Up to 1,200 g/t Ag, 7 g/t Au, 154.5 g/t In (Indium) investment picks
2015/2/2
By William Watts, MarketWatch Gold inflows strong in January, GLD leads the way NEW YORK (MarketWatch) -- Gold futures lost ground Monday, retreating as U.S. stocks looked to begin the week on a positive note, but remain up solidly for the year after posting the biggest monthly rise in three years in January.
Sign-up for 2015/2/2 - UPDATE: Gold sinks after biggest monthly rise in 3 years investment picks
2015/2/2
By John Revill ZURICH--Irish building materials company CRH PLC (CRH) still has the firepower to make further acquisitions despite being close to spending 6.5 billion euros ($7.34 billion) for some of the assets belonging to cement makers Lafarge SA and Holcim Ltd., CRH's chief executive said Monday.
Sign-up for 2015/2/2 - CRH: Still Able to Make Further Purchases After Lafarge, Holcim Asset Buys investment picks
2015/2/2
FRANKFURT--The following is a summary of analysts' forecasts for ABB Ltd (ABB) fourth-quarter results, based on a poll of 13 analysts conducted by Dow Jones Newswires (figures in million dollars, EPS in dollar, DPS and target price in franc, according to IFRS). Earnings figures are scheduled to be released February 5.
Sign-up for 2015/2/2 - ABB Ltd 4Q 2014 -- Forecast investment picks
2015/2/2
SAO PAULO , Jan.
Sign-up for 2015/2/2 - Follow our conference call: 2014 - 4th Quarter Results - Itau Unibanco Holding S.A. investment picks
2015/2/2
Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal 2015 financial results after the stock market closes on Feb.
Sign-up for 2015/2/2 - Agilent Technologies to Host Webcast of First-Quarter Fiscal Year 2015 Financial Results Conference Call investment picks
2015/2/2
Deutsche Bank today announced the launch of Deal Hub, a new collateral administration tool designed exclusively for collateralised loan obligation (CLO) managers to access their transactions via the Bank’s Autobahn App Market.
Sign-up for 2015/2/2 - Deutsche Bank Launches New Collateral Administration Tool for CLO Managers investment picks
2015/2/2
By Sue Chang and Victor Reklaitis, MarketWatch S&P downgrades Netflix deeper into junk territory SAN FRANCISCO (MarketWatch) -- These are the stocks making notable moves in the market on Monday: Gainers First Solar Inc.(FSLR) was singled out as a "top idea" in the clean energy sector by analysts at Brean Capital on Monday.
Sign-up for 2015/2/2 - UPDATE: First Solar, Chesapeake lead gainers, Moody's, Lululemon drop investment picks
2015/2/2
http://www.ccnmatthews.com/logos/20051130-pin200.jpg TORONTO, CANADA --
Sign-up for 2015/2/2 - Pinetree Capital Ltd. Announces Extension to Term Sheet With Supporting Debentureholders investment picks
2015/2/2
By Josie Cox European stocks fluctuated Monday as lingering concerns over the health of global economies, coupled with uncertainty surrounding debt negotiations in Greece, continued to spook investors.
Sign-up for 2015/2/2 - European Stocks Fluctuate on Global Growth Concerns -- 4th Update investment picks
2015/2/2
Shire PLC (SHPG) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on February 02, 2015.
Sign-up for 2015/2/2 - Shire Files 8K - Other Events investment picks
2015/2/2
RICHMOND, Va.
Sign-up for 2015/2/2 - Lingerfelt CommonWealth Partners Acquires Portfolio of Five Hotels investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2015/2/2 - Dicerna Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Clinical Trial of DCR-MYC, an Investigational RNAi Therapeutic Targeting the MYC Oncogene, in Patients with Advanced Hepatocellular Carcinoma to 2015/2/2 - Lingerfelt CommonWealth Partners Acquires Portfolio of Five Hotels
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent